OvaScience (OVAS) Announces Exercise Of Over-Allotment Option In Public Offering Of Common Stock
3/18/2014 9:28:47 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM, (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that the underwriters of its previously announced public offering of common stock have exercised their option to purchase an additional 518,630 shares of common stock at the public offering price of $10.00 per share. As a result, total gross proceeds to OvaScience from this offering are $55.2 million before deducting the underwriting discounts, commissions and estimated expenses.
Help employers find you! Check out all the jobs and post your resume.
comments powered by